Suhr, Dean
16  Ergebnisse:
Personensuche X
?
1

The power of a rare disease count and why an overcount is n..:

Suhr, Dean
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107330 , 2023
 
?
3

A proposal to efficiently improve diagnostic clarity, thera..:

Suhr, Dean
Molecular Genetics and Metabolism.  135 (2022)  2 - p. S117 , 2022
 
?
4

RANSIP newborn screening program: Working to bring early di..:

Suhr, Dean ; Suhr, Teryn R. ; Mathiesen, Tara.
Molecular Genetics and Metabolism.  132 (2021)  2 - p. S104-S105 , 2021
 
?
5

What do researchers, clinicians, industry employees, advoca..:

Suhr, Dean
Molecular Genetics and Metabolism.  129 (2020)  2 - p. S149 , 2020
 
?
6

Scientific, clinical, social, and policy status and conside..:

Suhr, Dean ; Suhr, Teryn R. ; Gelb, Michael H.
Molecular Genetics and Metabolism.  129 (2020)  2 - p. S149-S150 , 2020
 
?
7

Measuring sulfatide in blood enables newborn screening for ..:

Suhr, Dean
Molecular Genetics and Metabolism.  120 (2017)  1-2 - p. S128 , 2017
 
?
8

Disease specific therapies in leukodystrophies and leukoenc..:

Helman, Guy ; Van Haren, Keith ; Bonkowsky, Joshua L....
Molecular Genetics and Metabolism.  114 (2015)  4 - p. 527-536 , 2015
 
?
 
?
10

Newborn Screening - impact of new methods and criteria:

Suhr, Dean
Molecular Genetics and Metabolism.  111 (2014)  2 - p. S102 , 2014
 
?
11

The Open Registry Project as a Tool for Research and Clinic..:

Suhr, Dean
Molecular Genetics and Metabolism.  105 (2012)  2 - p. S59 , 2012
 
?
12

The evolving and expanding role of patient advocate groups ..:

Suhr, Dean
Molecular Genetics and Metabolism.  102 (2011)  2 - p. S42 , 2011
 
1-15